• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
How to Facilitate Decision-Making for Hematopoietic Stem Cell Transplantation in Patients With Hemoglobinopathies. The Perspectives of Healthcare Professionals.如何促进血红蛋白病患者造血干细胞移植的决策制定。医疗保健专业人员的观点。
Front Pediatr. 2021 Aug 18;9:690309. doi: 10.3389/fped.2021.690309. eCollection 2021.
2
Hoping for a normal life: Decision-making on hematopoietic stem cell transplantation by patients with a hemoglobinopathy and their caregivers.期待正常生活:血红蛋白病患者及其照顾者对造血干细胞移植的决策。
Pediatr Blood Cancer. 2024 Mar;71(3):e30808. doi: 10.1002/pbc.30808. Epub 2023 Dec 11.
3
Decision making for hematopoietic stem cell transplantation in pediatric, adolescent, and young adult patients with a hemoglobinopathy-Shared or not?患有血红蛋白病的儿科、青少年及年轻成人患者造血干细胞移植的决策——是否共享?
Pediatr Blood Cancer. 2021 Sep;68(9):e29099. doi: 10.1002/pbc.29099. Epub 2021 May 18.
4
Parental experiences in end-of-life decision-making in allogeneic pediatric stem cell transplantation: "Have I been a good parent?".父母在异基因儿科干细胞移植中的临终决策体验:“我是个好家长吗?”
Pediatr Blood Cancer. 2020 May;67(5):e28229. doi: 10.1002/pbc.28229. Epub 2020 Mar 5.
5
Experiences and Decision Making in Hematopoietic Stem Cell Transplant in Sickle Cell Disease: Patients' and Caregivers' Perspectives.镰状细胞病造血干细胞移植中的经验与决策:患者与照护者的观点。
Biol Blood Marrow Transplant. 2018 May;24(5):1041-1048. doi: 10.1016/j.bbmt.2017.11.018. Epub 2017 Nov 28.
6
Being in a space of sharing decision-making for dignified mental care.处于共享决策的空间,以实现有尊严的精神关怀。
J Psychiatr Ment Health Nurs. 2019 Nov;26(9-10):368-376. doi: 10.1111/jpm.12548. Epub 2019 Aug 23.
7
'They were aware of who I was as a person': Patients' and health professionals' experiences of using the PEGASUS intervention to facilitate decision-making around breast reconstruction.“他们了解我作为一个人的身份”:患者和健康专业人员在使用 PEGASUS 干预措施来促进乳房重建决策方面的经验。
Eur J Cancer Care (Engl). 2021 Sep;30(5):e13464. doi: 10.1111/ecc.13464. Epub 2021 May 24.
8
Professionals' preferences in prenatal counseling at the limits of viability: a nationwide qualitative Dutch study.生存极限下产前咨询中专业人员的偏好:一项荷兰全国性定性研究
Eur J Pediatr. 2017 Aug;176(8):1107-1119. doi: 10.1007/s00431-017-2952-6. Epub 2017 Jul 7.
9
Putting children forward for epilepsy surgery: A qualitative study of UK parents' and health professionals' decision-making experiences.让儿童接受癫痫手术:对英国父母及医疗专业人员决策经历的定性研究。
Epilepsy Behav. 2016 Aug;61:185-191. doi: 10.1016/j.yebeh.2016.05.037. Epub 2016 Jun 29.
10
Differences of sex development and surgical decisions: focus group interviews with health care professionals in Norway.性发育差异与手术决策:对挪威医疗保健专业人员的焦点小组访谈
Health Psychol Behav Med. 2024 Jul 6;12(1):2371134. doi: 10.1080/21642850.2024.2371134. eCollection 2024.

引用本文的文献

1
Oral health and quality of life in children with blood coagulation disorders and hemoglobinopathies. A cross-sectional study.凝血障碍和血红蛋白病患儿的口腔健康与生活质量。一项横断面研究。
J Family Med Prim Care. 2025 Jun;14(6):2497-2501. doi: 10.4103/jfmpc.jfmpc_1911_24. Epub 2025 Jun 30.
2
Improving shared decision‑making between paediatric haematologists, children with sickle cell disease, and their parents: an observational post-intervention study.改善儿科血液学家、镰状细胞病患儿及其父母之间的共同决策:一项干预后观察性研究。
Eur J Pediatr. 2025 Jun 12;184(7):417. doi: 10.1007/s00431-025-06241-2.
3
Balancing benefits and burdens: a systematic review on ethical and social dimensions of gene and cell therapies for hereditary blood diseases.权衡利弊:关于遗传性血液疾病基因和细胞疗法伦理与社会层面的系统评价
BMC Med Ethics. 2025 Mar 14;26(1):36. doi: 10.1186/s12910-025-01188-3.
4
Decision making on HSCT in patients with hemoglobinopathies; an EBMT Pediatric Diseases Working Party and Inborn Errors Working Party scenario-based survey on physicians' perspectives.血红蛋白病患者造血干细胞移植的决策制定;欧洲血液与骨髓移植协会儿科疾病工作组和先天性疾病工作组关于医生观点的基于情景的调查。
Bone Marrow Transplant. 2023 May;58(5):584-586. doi: 10.1038/s41409-023-01926-4. Epub 2023 Jan 26.

本文引用的文献

1
Decision making for hematopoietic stem cell transplantation in pediatric, adolescent, and young adult patients with a hemoglobinopathy-Shared or not?患有血红蛋白病的儿科、青少年及年轻成人患者造血干细胞移植的决策——是否共享?
Pediatr Blood Cancer. 2021 Sep;68(9):e29099. doi: 10.1002/pbc.29099. Epub 2021 May 18.
2
A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy.对造血干细胞移植或基因治疗后镰状细胞病和地中海贫血患者生活质量的系统评价。
Blood Adv. 2021 Jan 26;5(2):570-583. doi: 10.1182/bloodadvances.2020002948.
3
Hematopoietic Cell Transplantation for Sickle Cell Disease.镰状细胞病的造血细胞移植
Front Pediatr. 2021 Jan 5;8:551170. doi: 10.3389/fped.2020.551170. eCollection 2020.
4
Primary caregiver decision-making in hematopoietic cell transplantation and gene therapy for sickle cell disease.原发性照料者在造血干细胞移植和镰状细胞病基因治疗中的决策。
Pediatr Blood Cancer. 2021 Jan;68(1):e28749. doi: 10.1002/pbc.28749. Epub 2020 Oct 8.
5
Barriers and facilitators of pediatric shared decision-making: a systematic review.儿科共享决策的障碍和促进因素:系统评价。
Implement Sci. 2019 Jan 18;14(1):7. doi: 10.1186/s13012-018-0851-5.
6
Beyond transfusion therapy: new therapies in thalassemia including drugs, alternate donor transplant, and gene therapy.超越输血疗法:地中海贫血症的新疗法,包括药物、替代供体移植和基因疗法。
Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):361-370. doi: 10.1182/asheducation-2018.1.361.
7
Shared Decision-making in Pediatric Practice: A Broad View.儿科实践中的共享决策:广阔视角。
Pediatrics. 2018 Nov;142(Suppl 3):S129-S132. doi: 10.1542/peds.2018-0516B.
8
Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease.治疗方法:在镰状细胞病中,使用清髓性、减强度和非清髓性预处理,进行来自匹配相关供体的同种异体造血细胞移植。
Semin Hematol. 2018 Apr;55(2):87-93. doi: 10.1053/j.seminhematol.2018.04.011. Epub 2018 Apr 25.
9
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia.输血依赖型β-地中海贫血症患者的基因治疗。
N Engl J Med. 2018 Apr 19;378(16):1479-1493. doi: 10.1056/NEJMoa1705342.
10
Ethical Challenges in Hematopoietic Cell Transplantation for Sickle Cell Disease.造血干细胞移植治疗镰状细胞病的伦理挑战
Biol Blood Marrow Transplant. 2018 Feb;24(2):219-227. doi: 10.1016/j.bbmt.2017.08.034. Epub 2017 Sep 1.

如何促进血红蛋白病患者造血干细胞移植的决策制定。医疗保健专业人员的观点。

How to Facilitate Decision-Making for Hematopoietic Stem Cell Transplantation in Patients With Hemoglobinopathies. The Perspectives of Healthcare Professionals.

作者信息

Mekelenkamp Hilda, van Zanten Herma, de Vries Martine, Lankester Arjan, Smiers Frans

机构信息

Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Centre, Leiden, Netherlands.

Department of Medical Ethics and Health Law, Leiden University Medical Centre, Leiden, Netherlands.

出版信息

Front Pediatr. 2021 Aug 18;9:690309. doi: 10.3389/fped.2021.690309. eCollection 2021.

DOI:10.3389/fped.2021.690309
PMID:34485192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8416427/
Abstract

Hematopoietic stem cell transplantation decision-making for hemoglobinopathy patients is a complex process, and it remains difficult for health care professionals to decide whether and when a hematopoietic stem cell transplantation should be offered. Gaining insight into health care professionals' considerations is required to understand and optimize this decision-making process. A qualitative interview study using semi-structured interviews with eighteen health care professionals. Data were thematically analyzed. Two main themes emerged from the data: (1) and (2) . The frame of reference, meaning the health care professionals' knowledge and experiences regarding hematopoietic stem cell transplantation, influenced the guided decision-making process. Subsequently, three subthemes evolved from the second theme: (a) weighing up disease severity against possible complications, (b) making an effort to inform, and (c) supporting the best fitting decision for the individual patient. The health care professionals' frame of reference determined the hematopoietic stem cell transplantation decision-making process. This demands reflection on the health care professionals' own frame of reference and its influence on decision-making. Furthermore, reflection on the frame of reference is needed by exchange of knowledge and experiences between referring and referred-to healthcare professionals in an open and two-way direction. The transplantation teams have a responsibility of keeping the frame of reference of their referring colleagues up to date and referring health care professionals should share their feelings regarding hematopoietic stem cell transplantation. To guide patients, a shared decision-making approach is supportive, in which eliciting the patients' preferences is highly important. Health care professionals can refine the decision-making process by guiding patients in eliciting their preferences and including these in the decision.

摘要

血红蛋白病患者造血干细胞移植的决策是一个复杂的过程,医疗保健专业人员仍难以决定是否以及何时应提供造血干细胞移植。需要深入了解医疗保健专业人员的考虑因素,以理解和优化这一决策过程。一项定性访谈研究,对18名医疗保健专业人员进行了半结构化访谈。对数据进行了主题分析。数据中出现了两个主要主题:(1)和(2)。参考框架,即医疗保健专业人员关于造血干细胞移植的知识和经验,影响了指导性决策过程。随后,从第二个主题中衍生出三个子主题:(a)权衡疾病严重程度与可能的并发症,(b)努力提供信息,(c)支持为个体患者做出最合适的决策。医疗保健专业人员的参考框架决定了造血干细胞移植的决策过程。这需要反思医疗保健专业人员自身的参考框架及其对决策的影响。此外,需要通过转诊和被转诊的医疗保健专业人员之间开放和双向的知识与经验交流来反思参考框架。移植团队有责任使转诊同事的参考框架保持最新,转诊医疗保健专业人员应分享他们对造血干细胞移植的感受。为了指导患者,共同决策方法是有帮助的,其中了解患者的偏好非常重要。医疗保健专业人员可以通过指导患者了解他们的偏好并将其纳入决策来完善决策过程。